Sarepta Therapeutics Inc.

NASDAQ: SRPT · Real-Time Price · USD
21.71
1.41 (6.95%)
At close: Aug 15, 2025, 12:41 PM

Sarepta Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.9B 1.24B 933.01M 701.89M
Cost of Revenue
319.1M 150.34M 139.99M 97.05M
Gross Profit
1.58B 1.09B 793.02M 604.84M
Operating Income
218.08M -267.82M -536.2M -449.71M
Interest Income
71.77M 85.97M 27.72M 354K
Pretax Income
260.77M -520.1M -689.96M -418.95M
Net Income
235.24M -535.98M -703.49M -418.78M
Selling & General & Admin
557.87M 481.87M 451.42M 282.66M
Research & Development
804.52M 877.39M 877.09M 771.18M
Other Expenses
2.4M 1.56M 714K 706K
Operating Expenses
1.36B 1.36B 1.33B 1.05B
Interest Expense
18.39M 22.01M 53.25M 63.52M
Selling & Marketing Expenses
n/a 28.6M 14.6M 7.7M
Cost & Expenses
1.68B 1.51B 1.47B 1.15B
Income Tax Expense
25.54M 15.88M 13.53M -168K
Shares Outstanding (Basic)
95.08M 92.4M 87.56M 81.26M
Shares Outstanding (Diluted)
107.88M 92.4M 87.56M 81.26M
EPS (Basic)
2.34 -5.8 -8.03 -5.15
EPS (Diluted)
2.34 -5.8 -8.03 -5.15
EBITDA
333.06M -439.2M -582.12M -306.08M
EBIT
279.17M -498.09M -636.72M -355.42M
Depreciation & Amortization
53.89M 58.89M 54.6M 49.34M